Jillian B. Thomsen

Insider Reports History

Location
San Carlos, CA
Signature
Mark A. Wilson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jillian B. Thomsen:

Company Role Class Num Shares Value Price $ Report Date Ownership
NEKTAR THERAPEUTICS Chief Financial Officer Common Stock 313,497 $153,614 $0.4900 16 Feb 2023 Direct

Insider Reports Filed by Jillian B. Thomsen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NKTR NEKTAR THERAPEUTICS 16 Feb 2023 1 -$30,801 4 Chief Financial Officer 17 Feb 2023, 19:58
NKTR NEKTAR THERAPEUTICS 16 Nov 2022 1 -$39,609 4 Chief Financial Officer 18 Nov 2022, 17:03
NKTR NEKTAR THERAPEUTICS 15 Aug 2022 3 -$9,549 4 SVP & Chief Accounting Officer 17 Aug 2022, 19:40
NKTR NEKTAR THERAPEUTICS 15 May 2022 2 -$23,072 4 SVP & Chief Accounting Officer 17 May 2022, 21:36
NKTR NEKTAR THERAPEUTICS 16 Feb 2022 1 -$25,875 4 SVP & Chief Accounting Officer 18 Feb 2022, 17:18
NKTR NEKTAR THERAPEUTICS 16 Dec 2021 2 $0 4 SVP & Chief Accounting Officer 20 Dec 2021, 19:26
NKTR NEKTAR THERAPEUTICS 15 Nov 2021 2 -$88,712 4 SVP & Chief Accounting Officer 17 Nov 2021, 17:08
NKTR NEKTAR THERAPEUTICS 12 Oct 2021 1 $0 4 SVP & Chief Accounting Officer 14 Oct 2021, 21:07
NKTR NEKTAR THERAPEUTICS 16 Aug 2021 1 -$184,478 4 SVP & Chief Accounting Officer 18 Aug 2021, 19:00
NKTR NEKTAR THERAPEUTICS 17 May 2021 1 -$245,055 4 SVP & Chief Accounting Officer 19 May 2021, 19:06